IP Library Granted Patent US 7,214,388
Granted Patent B2
US 7,214,388 · App. 10/684,692 · Granted May 8, 2007

Degradable heterobifunctional poly(ethylene glycol) acrylates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,214,388
App. No.
10/684,692
Granted
May 8, 2007
Kind
B2
Abstract

A heterobifunctional poly(ethylene glycol) is provided having a hydrolytically degradable linkage, a first terminus comprising an acrylate group, and a second terminus comprising a target such as a protein or pharmaceutical agent or a reactive moiety capable of coupling to a target. Hydrogels can be prepared. The hydrogels can be used as a carrier for a protein or a pharmaceutical agent that can be readily released in a controlled fashion.

Claims (10)

1. A heterobifunctional compound represented by the formula:

CH 2 ═CZ-CO 2 -POLY-W-POLY′-Q

where

Z represents H or alkyl;

POLY and POLY′ are poly(alkylene oxide) groups that can be the same or different and are represented by the formula —(CH 2 CHRO) n —CH 2 CHR— in which R is H or alkyl, and n ranges from about 10 to about 4000;

Q represents a functional group other than an acrylate group; and

W represents a hydrolytically unstable linkage that hydrolyzes at pH 7 and 37° C.

2. The compound of claim 1 , wherein POLY and POLY′ are poly(ethylene glycol).

3. The compound of claim 1 , wherein W comprises a hydrolyzable covalent bond selected from the group consisting of esters, orthoesters, imines, acetals, peptide bonds, phosphate esters, and oligonucleotides.

4. The compound of claim 1 , wherein Q is selected from the group consisting of aldehydes, carboxylic acids, sulfonate esters, amines, hydrazides, orthopyridyl disulfides, thiols, carbonate esters, N-susuccinimidyl esters, isocyanates, alcohols, and epoxide.

Assignments (1)
MERGER Recorded Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →